PLIMOTH TRUST CO LLC: DCI position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PLIMOTH TRUST CO LLC on DCI, newest first. How the timeline and the estimate are built.
PLIMOTH TRUST CO LLC held 3,000 DCI shares at 2026-06-30 per its 13F-HR filed 2026-07-28.
the latest 13F is the newest step
- period ended2026-06-3013F 3,000 sharesChange vs previous 13F 0 shares
0.05% of the 13F portfolio, value $269,310.
13F-HR 0001623678-26-000003 filed by PLIMOTH TRUST CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 3,000 sharesChange vs previous 13F 0 shares
0.06% of the 13F portfolio, value $254,610.
13F-HR 0001623678-26-000002 filed by PLIMOTH TRUST CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 3,000 sharesChange vs previous 13F 0 shares
0.06% of the 13F portfolio, value $265,980.
13F-HR 0001623678-26-000001 filed by PLIMOTH TRUST CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,000 sharesChange vs previous 13F 0 shares
0.06% of the 13F portfolio, value $245,550.
13F-HR 0001623678-25-000007 filed by PLIMOTH TRUST CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,000 sharesChange vs previous 13F 0 shares
0.05% of the 13F portfolio, value $208,050.
13F-HR 0001623678-25-000005 filed by PLIMOTH TRUST CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,000 sharesChange vs previous 13F not available
0.05% of the 13F portfolio, value $201,180.
13F-HR 0001623678-25-000002 filed by PLIMOTH TRUST CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).